TALEN-mediated Nanog disruption results in less invasiveness, more chemosensitivity and reversal of EMT in Hela cells

被引:31
作者
Ding, Yan [1 ,2 ]
Yu, Ai Qing [1 ]
Li, Cheng Lin [1 ]
Fang, Juan [1 ]
Zeng, Yi [2 ]
Li, Dong Sheng [1 ]
机构
[1] Hubei Univ Med, Taihe Hosp, Hubei Key Lab Embryon Stem Cell Res, Shiyan, Hubei, Peoples R China
[2] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China
关键词
Nanog; Hela cell; cervical cancer cell; TALEN; epithelial-mesenchymal transition; MULTIDRUG-RESISTANCE; STEM; PLURIPOTENCY; CADHERIN;
D O I
10.18632/oncotarget.2298
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Emerging evidence suggests that Nanog is involved in cervical tumorigenesis. However, the regulating role of Nanog in tumorigenesis and chemosensitivity are still poorly understood. In this study, Nanog was disrupted by transcription activator-like effector nucleases (TALEN) in Hela cells and its expression was significantly decreased in a single-cell derived sub-clone with biallelic mutations. The disruption of Nanog not only induced down regulation of some other core transcription factor genes for cell self-renewal, such as Oct4, Sox2 and FoxD3, but also led to the down regulation of some mesenchymal representative genes, vimentin and N-adherin, and up regulation of the epithelial gene, E-cadherin. In addition, the invasiveness and clonogenicity of the Hela cells were obviously affected, and surprisingly their sensitivities to anti-cancer drugs were also significantly increased in vitro. After Xenograft into nude mice, the growth volumes of the neoplasms from the Nanog disrupted Hela cells were significantly smaller compared with those from wild type ones. In conclusion, these results suggest that disruption of Nanog may reverse the status of epithelial-mesenchymal transition, which is critical in tumorigenesis, and alleviate chemoresistance, as well as their invasiveness, in cervical cancer cells.
引用
收藏
页码:8393 / 8401
页数:9
相关论文
共 24 条
[1]   The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line [J].
Adey, Andrew ;
Burton, Joshua N. ;
Kitzman, Jacob O. ;
Hiatt, Joseph B. ;
Lewis, Alexandra P. ;
Martin, Beth K. ;
Qiu, Ruolan ;
Lee, Choli ;
Shendure, Jay .
NATURE, 2013, 500 (7461) :207-+
[2]  
[Anonymous], CELL CYCLE
[3]  
[Anonymous], CELL CYCLE
[4]   An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors [J].
Ben-Porath, Ittai ;
Thomson, Matthew W. ;
Carey, Vincent J. ;
Ge, Ruping ;
Bell, George W. ;
Regev, Aviv ;
Weinberg, Robert A. .
NATURE GENETICS, 2008, 40 (05) :499-507
[5]   Highly efficient generation of heritable zebrafish gene mutations using homo- and heterodimeric TALENs [J].
Cade, Lindsay ;
Reyon, Deepak ;
Hwang, Woong Y. ;
Tsai, Shengdar Q. ;
Patel, Samir ;
Khayter, Cyd ;
Joung, J. Keith ;
Sander, Jeffry D. ;
Peterson, Randall T. ;
Yeh, Jing-Ruey Joanna .
NUCLEIC ACIDS RESEARCH, 2012, 40 (16) :8001-8010
[6]   Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells [J].
Chambers, I ;
Colby, D ;
Robertson, M ;
Nichols, J ;
Lee, S ;
Tweedie, S ;
Smith, A .
CELL, 2003, 113 (05) :643-655
[7]   Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells [J].
Ding, Zhen-Yu ;
Liu, Gui-Hong ;
Olsson, Birgit ;
Sun, Xiao-Feng .
TUMOR BIOLOGY, 2013, 34 (02) :683-693
[8]   Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract [J].
Freberg, Christel T. ;
Dahl, John Arne ;
Timoskainen, Sanna ;
Collas, Philippe .
MOLECULAR BIOLOGY OF THE CELL, 2007, 18 (05) :1543-1553
[9]   Multidrug Resistance Through the Spectacle of P-Glycoprotein [J].
Goda, Katalin ;
Bacso, Zsolt ;
Szabo, Gabor .
CURRENT CANCER DRUG TARGETS, 2009, 9 (03) :281-297
[10]   Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo [J].
Gu, Guangyu ;
Yuan, Jialing ;
Wils, Marcia ;
Kasper, Susan .
CANCER RESEARCH, 2007, 67 (10) :4807-4815